Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20081
20102
20112
20121
20181
20191
20201
20213
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting3
Enrolling by invitation2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma5
Human Genome Sciences Inc., a GSK Company3
UCB Biopharma SRL3
Biogen2
Eli Lilly and Company2
AbbVie1
AstraZeneca1
Cephalon, Inc.1
Human Genome Sciences Inc.1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic20
Autoimmune Diseases4
Lupus Nephritis2
Arthritis, Juvenile1
Connective Tissue Diseases1
Glomerulonephritis1
Immune System Diseases1
Kidney Diseases1
Macrophage Activation Syndrome1
Nephritis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.